SCHEMBL2800267

SCHEMBL2800267

CC(O)(C=O)N1CCOCC1

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.37
USP2 O75604 1/20 0.37
ALDH1A1 P00352 6/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
HPGD P15428 1/20 0.35
RECQL P46063 1/20 0.33
GAA P10253 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5430692 0.79 CYP2B6 (0.30)
SCHEMBL5440043 0.77 CYP2B6 (0.33) SMN1; SMN2ALDH1A1RAB9ANPC1MEN1
SCHEMBL1266718 0.77 SMN1; SMN2 (0.35) SMN1; SMN2USP2ALDH1A1TSHRMAPK1
SCHEMBL5440185 0.74 HPGD (0.35) HPGDCA12CA1CA9
SCHEMBL23887411 0.74 SMN1; SMN2 (0.39) SMN1; SMN2USP2ALDH1A1TSHRMAPK1
SCHEMBL20565115 0.74 SMN1; SMN2 (0.39) SMN1; SMN2USP2ALDH1A1TSHRMAPK1
SCHEMBL3103737 0.74 SMN1; SMN2 (0.39) SMN1; SMN2USP2ALDH1A1TSHRMAPK1
SCHEMBL20416441 0.71 SMN1; SMN2 (0.32) SMN1; SMN2USP2ALDH1A1TSHRMAPK1
SCHEMBL17713882 0.70 SMN1; SMN2 (0.38) SMN1; SMN2USP2ALDH1A1TSHRMAPK1
SCHEMBL12928715 0.68 SMN1; SMN2 (0.48) SMN1; SMN2USP2ALDH1A1TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007505874-A 2007-03-15 JP claimed
EP-1664029-A1 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS AstraZeneca AB (SE) 2006-06-07 EP claimed
WO-2005026152-A1 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS ASTRAZENECA AB (SE) 2005-03-24 WO claimed
US-7764339-B2 Liquid crystal display device DAI NIPPON PRINTING CO., LTD. (JP) 2010-07-27 US disclosed
US-20090109376-A1 Liquid Crystal Display Device DAI NIPPON PRINTING CO., LTD. (JP) 2009-04-30 US disclosed